Merck & Co.
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Merck & Co. (MRK) Business News
Track Merck & Co. in real time with a live news feed covering Merck & Co. stock news, official press releases, company announcements, and an archive of historical Merck & Co. news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership’s 10th Largest Position
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Capital Group Private Client Services Inc. Lowers Stock Position in Merck & Co., Inc. $MRK
Capital International Inc. CA Cuts Position in Merck & Co., Inc. $MRK
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Capital Group Private Client Services Inc. Lowers Stock Position in Merck & Co., Inc. $MRK
Capital International Inc. CA Cuts Position in Merck & Co., Inc. $MRK
Harbor Health Care ETF Q4 2025 Portfolio Review
Merck & Co., Inc. $MRK Shares Sold by Beese Fulmer Investment Management Inc.
Merck & Co., Inc. $MRK Shares Sold by Barrow Hanley Mewhinney & Strauss LLC
Diversify Advisory Services LLC Cuts Holdings in Merck & Co., Inc. $MRK
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
DLD Asset Management LP Has $3.99 Billion Stock Position in Merck & Co., Inc. $MRK
Flavin Financial Services Inc. Boosts Stock Holdings in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership’s 10th Largest Position
3:58 AM | Friday | Mar 13, 2026
Arrowstreet Capital Limited Partnership cut its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 3.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,708,703 shares of the company's stock after selling 747,393 shares during
Read full article
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership’s 10th Largest Position
Defense WorldArrowstreet Capital Limited Partnership cut its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 3.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,708,703 shares of the company's stock after selling 747,393 shares during
Read full article
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
24/7 Wall StreetMerck & Co., Inc. ( NYSE:MRK ) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.
Read full article
Capital Group Private Client Services Inc. Lowers Stock Position in Merck & Co., Inc. $MRK
Defense WorldCapital Group Private Client Services Inc. trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 94.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
The firm owned 5,641 shares of the company's stock after selling 90,339
Capital International Inc. CA Cuts Position in Merck & Co., Inc. $MRK
Defense WorldCapital International Inc. CA trimmed its position in shares of Merck and Co., Inc. (NYSE: MRK) by 37.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 12,745 shares of the company's stock after selling 7,639 shares during the period.
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
24/7 Wall StreetMerck & Co., Inc. ( NYSE:MRK ) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.
Read full article
Capital Group Private Client Services Inc. Lowers Stock Position in Merck & Co., Inc. $MRK
Defense WorldCapital Group Private Client Services Inc. trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 94.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
The firm owned 5,641 shares of the company's stock after selling 90,339
Capital International Inc. CA Cuts Position in Merck & Co., Inc. $MRK
Defense WorldCapital International Inc. CA trimmed its position in shares of Merck and Co., Inc. (NYSE: MRK) by 37.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 12,745 shares of the company's stock after selling 7,639 shares during the period.
Harbor Health Care ETF Q4 2025 Portfolio Review
Seeking AlphaRevolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly delivered strong absolute performance — driven by continued GLP-1 demand and the FDA approval of Zepbound — our underweight position in the name was a significant detractor from relative results. During the quarter, we purchased Avidity Biosciences, a clinical-stage biopharma company focused on RNA therapies for rare muscle diseases, and Abivax SA, a clinical-stage biopharma company focused on chronic inflammatory diseases.
Read full article
Merck & Co., Inc. $MRK Shares Sold by Beese Fulmer Investment Management Inc.
Defense WorldBeese Fulmer Investment Management Inc. decreased its position in Merck and Co., Inc. (NYSE: MRK) by 7.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The fund owned 154,887 shares of the company's stock after selling 12,251 shares during the period. Beese Fulmer
Merck & Co., Inc. $MRK Shares Sold by Barrow Hanley Mewhinney & Strauss LLC
Defense WorldBarrow Hanley Mewhinney and Strauss LLC lessened its position in shares of Merck and Co., Inc. (NYSE: MRK) by 14.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,415,270 shares of the company's stock after selling 1,291,412 shares
Read full article
Diversify Advisory Services LLC Cuts Holdings in Merck & Co., Inc. $MRK
Defense WorldDiversify Advisory Services LLC reduced its position in shares of Merck and Co., Inc. (NYSE: MRK) by 38.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,884 shares of the company's stock after selling 12,372 shares during the
Read full article
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
Zacks Investment ResearchMerck faces continued pressure as Gardasil sales slump 39% in 2025, hit by weak China demand, with management expecting no rebound in 2026.
Read full article
DLD Asset Management LP Has $3.99 Billion Stock Position in Merck & Co., Inc. $MRK
Defense WorldDLD Asset Management LP raised its holdings in Merck and Co., Inc. (NYSE: MRK) by 30.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,500,000 shares of the company's stock after buying an additional 11,000,000 shares during the quarter.
Merck and
Flavin Financial Services Inc. Boosts Stock Holdings in Merck & Co., Inc. $MRK
Defense WorldFlavin Financial Services Inc. raised its position in shares of Merck and Co., Inc. (NYSE: MRK) by 27.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The fund owned 21,052 shares of the company's stock after acquiring an additional 4,481 shares during